Biodistribution of 125I-MAb 425 in a human glioma xenograft model: Effect of chloroquine

Hybridoma

Volumn 16, Issue 1, 1997, Pages 93-100

  Emrich, Jacqueline G ^a   Hand, Christopher M ^a   Dilling, Thomas J ^a   Class, Reiner ^a   Bender, Hans ^b   Brady, Luther W ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; EPIDERMAL GROWTH FACTOR RECEPTOR; IODINE 125; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 425 I 125; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIOACCUMULATION; CANCER TRANSPLANTATION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GLIOMA; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION; RAT; STEREOTAXIC SURGERY; TISSUE DISTRIBUTION; TUMOR XENOGRAFT; ANIMAL; ARTICLE; BRAIN TUMOR; CELL CULTURE; DISEASE MODEL; DRUG EFFECT; HUMAN; IMMUNOLOGY; METABOLISM; NUDE RAT; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; CHLOROQUINE; DISEASE MODELS, ANIMAL; GLIOMA; HUMANS; RATS; RATS, NUDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030610293     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1997.16.93     Document Type: Conference Paper

References (20)

1. Parker SL, Tong T, Bolden S, and Wingo PA: Cancer Statistics. CA-A Cancer Journal for Clinicians 1996;46:5-27.
2. Hopkins K, Papanastassiou V, and Kemshead JT: Systemic Radiotherapy with Monoclonal Antibodies. Sautter-Bihl M-L, Bihl H, and Wannenmacher M (Eds.). Springer Verlag, Berlin, 1996, pp. 159-175.
3. 125I labeled monoclonal antibody against epidermal growth factor receptor. Antibod Immunoconj Radiopharm 1990;3:169-179.
4. Brady LW, Markoe AM, Woo DV, Amendola BE, Karlsson U, Rackover MA, Koprowski H, Steplewski Z, and Peyster RG: Iodine-125 labeled anti-epidermal growth factor receptor-425 in the treatment of glioblastoma multiforme. Front Rad Ther Oncol 1990;24:151-160.
5. Brady LW, Miyamoto C, Woo DV, Rackover M, Emrich J, Bender H, Dadparvar S, Steplewski Z, Koprowski H, Black P, Lazzaro B, Nair S, McCormack T, Nieves J, Morabito M, and Eshleman J: Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial. Int J Radiat Oncol Biol Phys 1992;22:225-230.
6. Miyamoto C, Brady LW, Rackover M, Emrich J, Class R, Bender H, Dadparvar S, Woo D, Young T, Eshleman J, Micaily B, Steplewski Z, Koprowski H, Black P, Nair S, and McCormack T: Utilization of the 125Iodine labeled MAb 425 in the management of primary glioblastoma multiforme. Radiat Oncol Invest 1995:3:126-132.
7. Miyamoto C, Brady LW, Rackover MA, Emrich J, Class R, Bender H, Micaily B, and Steplewski Z: Systemic Radiotherapy with Monoclonal Antibodies. Sautter-Bihl M-L, Bihl H, Wannenmacher M (Eds.). Springer Verlag, Berlin, 1996, pp. 183-192.
8. 125I-labeled monoclonal antibody 425 against cancer cells containing epidermal growth factor receptor. Am J Clin Oncol (CCT) 1992:15:288-294.
9. Emrich JG, Bender H, Class R, Eshleman J, Miyamoto C, and Brady LW: In vitro evaluation of iodine-125 labeled monoclonal antibody MAb 425 in human high grade glioma cells. Am J Clin Oncol (CCT) 1996;19(6):601-608.
10. 125I-MAb 425 to human glioma cells in vitro using chloroquine." Ph.D. thesis, 1993.
11. Herlyn M, Thurin J, Balaban G, Bennicell JL, Herlyn D, Elder DE, Bondi E, Guerry D, Noell P, Clark WJ, and Koprowski H: Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 1985;45:5670-5676.
12. Murthy U, Basu A, Rodeck U, Herlyn M, Ross AH, and Das M: Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptie. Arch Biochem Biophys 1987;2523:549-560.
13. Markwell MAK, and Fox CF: Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3α6-diphenyl glycoluril. Biochemistry 1978:17:4807-4817.
14. Takahashi H, Belser PH, Atkinson BF, Sela B-A, Ross AH, Biegel J, Emmanuel B, Sutton L, Koprowski H, and Herlyn D: Monoclonal antibody-dependent cell mediated cytotoxicity against human malignant gliomas. Neurosurgery 1990:27:97-102.
15. Finkelstein SD, Black P, Nowak TP, Hand CM, Christensen S, and Finch PW: Histological characteristics and expression of acidic and basic fibroblast growth factor genes in intracerebral xenogeneic transplants of human glioma cells. Neurosurgery 1994:34:136-143.
16. Buchsbaum DJ, and Lawrence TS: Tumor therapy with radiolabeled monoclonal antibodies. Antibod Immunoconj Radiopharm 1991;4:245-272.
17. Wheldon TE: Targeting radiation to tumors. Int J Radiat Biol 1994;65:109-116.
18. Woo DV, Li D, Brady LW, Emrich J, Mattis J, and Steplewski Z: The Present and Future Role of Monoclonal Antibodies in the Management of Cancer. Vaeth JM, and Meyer JL (Eds.). S. Karger, Basel, Switzerland, 1990, pp. 47-63.
19. Salcman M, and Kaplan RS: Comprehensive Textbook of Oncology. Moossa AR, Schimpff SC, Robson MC (Eds.). Volume 2,2nd ed. Williams & Wilkins, Baltimore, 1991, pp. 1339-1352.
20. Bleehen MM: Studies on high grade cerebral giomas. Int J Radiat Oncol Biol Phys 1990;18:811-813.